|
|
|
百達生物科技基金-R(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
649.34 |
-11.21 |
-1.70% |
2020/04/08 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 7.01% |
-8.76% |
24.37% |
55.46% |
24.10% |
9.00% |
-25.02% |
23.50% |
-15.44% |
29.97% |
| 百達生物科技基金-R(美元)
| |
此成分基金的目標是至少以其總資產的三分之二投資於由在生物科技醫藥行業中較為創新的公司所發行的股份，以達致資本增長。此成分基金的投資並沒有地域上的限制，但由於北美及歐洲在醫藥行業較為創新，此成分基金的大部分投資亦集中於這些地區。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/04/08 |
649.34 |
-1.70% |
2020/03/23 |
570.88 |
-6.18% |
| 2020/04/07 |
660.55 |
2.04% |
2020/03/20 |
608.48 |
4.13% |
| 2020/04/06 |
647.37 |
2.73% |
2020/03/19 |
584.34 |
0.48% |
| 2020/04/03 |
630.16 |
0.32% |
2020/03/18 |
581.56 |
0.60% |
| 2020/03/31 |
628.15 |
0.43% |
2020/03/17 |
578.09 |
-1.08% |
| 2020/03/30 |
625.48 |
1.53% |
2020/03/16 |
584.40 |
0.23% |
| 2020/03/27 |
616.06 |
-0.79% |
2020/03/13 |
583.05 |
-2.56% |
| 2020/03/26 |
620.96 |
2.98% |
2020/03/12 |
598.36 |
-7.45% |
| 2020/03/25 |
603.01 |
1.43% |
2020/03/11 |
646.56 |
-0.01% |
| 2020/03/24 |
594.51 |
4.14% |
2020/03/10 |
646.65 |
-0.93% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-1.70% |
3.37% |
-5.87% |
-7.22% |
15.65% |
-0.44% |
-7.52% |
| NBI生技指數 |
2.92% |
8.91% |
-4.41% |
-6.13% |
15.80% |
-1.32% |
-6.32% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
2.90% |
9.07% |
-3.74% |
-7.50% |
15.29% |
-9.61% |
-6.76% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
4.87% |
-6.26% |
-10.29% |
3.83% |
0.69% |
-10.26% |
| MSCI 製藥指數 (price) |
0.00% |
3.95% |
-4.70% |
-8.58% |
3.11% |
0.10% |
-9.16% |
| MSCI 生物科技指數 (price) |
0.00% |
4.36% |
-4.71% |
-3.60% |
15.98% |
6.51% |
-3.19% |
|
2.61% |
7.74% |
-3.50% |
-6.33% |
7.46% |
3.00% |
-6.21% |
|
2.61% |
7.72% |
-3.58% |
-6.56% |
6.92% |
1.97% |
-6.47% |
|
-1.92% |
2.38% |
-5.15% |
-4.21% |
16.78% |
2.50% |
-5.05% |
|
-2.22% |
0.95% |
-8.18% |
-9.27% |
6.31% |
-8.26% |
-10.16% |
|
-1.83% |
4.35% |
-1.38% |
-7.80% |
4.89% |
7.25% |
-6.74% |
|
-2.14% |
3.89% |
-5.43% |
-9.81% |
4.01% |
3.53% |
-9.55% |
|
-0.93% |
1.23% |
-5.24% |
-8.28% |
6.78% |
2.49% |
-8.14% |
|
-1.82% |
1.27% |
-5.33% |
-7.75% |
-1.76% |
-4.43% |
-7.92% |
|
-1.54% |
1.62% |
-5.62% |
-7.95% |
0.68% |
-2.30% |
-8.03% |
|
1.64% |
7.41% |
-9.56% |
-12.06% |
-7.10% |
6.26% |
-16.02% |
|
1.16% |
4.15% |
-1.52% |
-8.48% |
1.27% |
5.30% |
-7.54% |
|
2.81% |
9.73% |
-7.14% |
-9.41% |
17.96% |
-0.19% |
-8.80% |
|
2.80% |
9.67% |
-7.25% |
-9.73% |
17.18% |
-1.50% |
-9.14% |
|
-3.44% |
1.04% |
-8.01% |
-15.09% |
1.15% |
-1.72% |
-15.40% |
|
2.99% |
8.83% |
-5.29% |
-10.46% |
9.24% |
-0.94% |
-10.37% |
|
3.02% |
8.84% |
-5.35% |
-10.66% |
8.71% |
-1.90% |
-10.60% |
|
3.00% |
8.81% |
-5.76% |
-11.19% |
7.57% |
-4.05% |
-11.17% |
|
3.00% |
8.83% |
-5.71% |
-11.03% |
7.99% |
-3.32% |
-10.98% |
|
3.00% |
8.86% |
-5.23% |
-10.29% |
9.67% |
-0.17% |
-10.19% |
|
-1.25% |
1.16% |
-3.43% |
-2.84% |
8.18% |
1.75% |
-3.59% |
|
-1.71% |
3.27% |
-6.17% |
-7.85% |
14.04% |
-3.35% |
-8.20% |
|
-1.40% |
4.07% |
-1.85% |
-5.14% |
16.62% |
3.15% |
-4.64% |
|
-1.75% |
1.80% |
-9.34% |
-15.86% |
-5.53% |
-10.31% |
-16.01% |
|
-1.44% |
2.60% |
-5.12% |
-13.36% |
-3.37% |
-4.21% |
-12.73% |
|
-1.73% |
1.93% |
-8.99% |
-15.25% |
-4.17% |
-7.54% |
-15.36% |
|
-1.39% |
2.22% |
-7.83% |
-7.93% |
12.13% |
-3.98% |
-8.82% |
|
-0.11% |
2.35% |
-7.55% |
-12.48% |
0.11% |
-1.45% |
-12.83% |
|
-1.35% |
1.19% |
-6.57% |
-6.91% |
9.17% |
2.40% |
-7.08% |
|
-0.55% |
1.12% |
-9.55% |
-11.55% |
5.88% |
-2.44% |
-12.20% |
| 基金平均績效 |
-0.05% |
4.41% |
-5.88% |
-9.43% |
6.48% |
-0.76% |
-9.58% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
